CEU 2019: Diabetes Session Recordings
CEU 2019: Diabetes Session Recordings
Use the links in the table below to go to the CEU Topical Courses to start the activities. Click one of the buttons below the table to visit the Endocrine Society store for purchase options.
Access the latest clinical endocrine updates
Earn AMA PRA Category 1 Credits™
Download mp3 audio files to listen on the go
|Session Title||Featured Speaker||Session Duration|
|Diabetes on a Budget||David Matthew Nathan MD||0:40|
|Contemporary Management of T1D in Pregnancy||Carol J. Levy MD CDE||0:30|
|Update on Diabetic Nephropathy||Robert C. Stanton MD||0:30|
|Q&A/Panel Discussion||David Matthew Nathan MD, Carol J. Levy MD CDE, Robert C. Stanton MD||0:15|
|Glycemic Management after Bariatric Surgery||Mary-Elizabeth Patti MD||0:30|
|Safety of Novel Agents in T2D Management||Carol Wysham MD||0:30|
|Challenges with Technology: Difficult Pump and CGM Cases||Anders L. Carlson MD||0:30|
|Q&A/Panel Discussion||Mary-Elizabeth Patti MD, Carol Wysham MD, Anders L. Carlson MD||0:20|
|Treatment of Diabetes in the Elderly||Mark E. Molitch MD||0:45|
|Revisiting Old Drugs for T2D||David Matthew Nathan MD||0:45|
|Challenges in the Evaluation and Management of Hypoglycemia||Mary-Elizabeth Patti MD||0:45|
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to The Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.
The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of the Endocrine Society.
USE OF PROFESSIONAL JUDGMENT:
The educational content in this self-assessment test relates to basic principles of diagnosis and therapy and does not substitute for individual patient assessment based on the health care provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient. Standards in medicine change as new data become available.
DRUGS AND DOSAGES:
When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.
PRIVACY AND CONFIDENTIALITY STATEMENT
The Endocrine Society will record learner’s personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.
ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
The Endocrine Society is proud to partner with industry to advance excellence and promote scientific discovery, medical practice and human health. This educational activity is supported by an independent medical educational grant from Lilly USA, LLC, Medtronic Diabetes, Merck & Co., Inc., and Xeris Pharmaceuticals.
The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation. The Endocrine Society designates this enduring activity for a maximum of 6.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 6.00 AMA PRA Category 1 Credits™
- 6.00 CME Certificate of Participation
Click the Start button to begin the course.
If you are not enrolled, click the button below to go to the Endocrine Society Store to see purchase options.